AI-generated summary
In this study in mice, the authors examined whether photobiomodulation applied to fetal intestinal grafts affects acute rejection. They report that treated grafts had lower rejection scores on days 5 and 7 and better development, along with reduced activation markers on T cells in spleens. The abstract describes this as an animal study without a stated human outcome, so the findings may not apply to people.
- Participants
- 77
- Who or what was studied
- Mice: C57BL/6 donors and BALB/c recipients in the histology phase, and 30 transplanted mice in the flow cytometry phase
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The abstract describes an animal study and does not report a human population or clinical outcomes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Acute rejection remains a significant challenge in organ transplantation. Photobiomodulation (PBM) has demonstrated anti-inflammatory and regenerative properties, suggesting potential benefits in modulating immune responses. This study aimed to evaluate the effects of PBM on fetal intestinal transplantation in mice. The study was conducted in two phases. In the first phase, 77 mice were utilized to assess histological outcomes. Fetal intestines from pregnant C57BL/6 mice were transplanted into BALB/c recipients, forming allogeneic groups (ALLO-GTx) with or without PBM (ALLO-GTxPBM), and syngeneic controls (RG). PBM was applied transcutaneous at the graft site immediately post-surgery (660 nm, 40 J/cm², 1.5 J). Grafts were collected on postoperative days 3, 5, and 7 for hematoxylin-eosin staining and evaluated using Aubert's criteria. In the second phase, spleens from 30 transplanted mice were analyzed on day 7 via flow cytometry for lymphocyte activation markers (CD4+, CD8+, CD44, CD69, CD54, CD62L). PBM significantly reduced rejection scores on days 5 (3.5 [3-9] vs. 12 [10-13.8]; p = 0.0006) and 7 (p = 0.0096), and enhanced graft development (p = 0.0079). Flow cytometry revealed decreased activation of CD4 + CD44+CD69+ (9.08% to 3.15%) and CD8 + CD44+CD69+ (1.53% to 0.90%) T cells in PBM-treated animals. Additionally, lower expression levels of CD62L + and CD54 were observed, indicating immunomodulatory effects. PBM improved graft viability and mitigated acute rejection in fetal intestinal transplantation in mice. These findings support further investigation into PBM as a therapeutic strategy to modulate immune responses in transplantation.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Total energy
- 1.5 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.